Comprehensive Malaria Diagnosis: The  PV/PF Malaria Rapid Card represents a cutting-edge diagnostic tool intended for the qualitative and differential detection of Plasmodium vivax (Pv) and Plasmodium falciparum (Pf) in human whole blood. Leveraging lateral flow immunoassay technology, this rapid card test serves as a crucial aid in the swift and accurate diagnosis of Malaria, enabling healthcare professionals to promptly identify and differentiate between the two common strains of the Malaria parasite.

Enhanced Sensitivity and Specificity: Featuring highly specific monoclonal antibodies specific to pLDH (Pv) and HRP-II (Pf), the Oscar PV/PF Malaria Rapid Card offers superior sensitivity and specificity for the detection of Pv and Pf. This advanced formulation ensures accurate and reliable test results, minimizing the risk of false positives and false negatives and providing healthcare providers with dependable diagnostic insights for effective patient management and treatment decisions.

Innovative Immunoassay Technology: Built upon lateral flow immunoassay technology, the Oscar Malaria Antigen Pv/Pf card test delivers rapid and efficient results, facilitating quick and precise diagnosis of Malaria in diverse clinical settings. Its user-friendly design and simplified testing protocols make it an indispensable tool for healthcare providers, streamlining the diagnostic process and enabling efficient and reliable Malaria testing practices.

Qualitative and Differential Detection Precision: Engineered for qualitative and differential detection, the Oscar PV/PF Malaria Rapid Card offers precise and reliable results, enabling healthcare professionals to accurately differentiate between Pv and Pf strains, crucial for tailoring appropriate treatment approaches and interventions for patients infected with either strain. This precision in detection enhances the diagnostic process, enabling healthcare providers to make informed decisions and implement timely and effective Malaria management strategies.